CDKN1A and cancer: Hence, we postulate that the SOCS1-mediated degradation of p21 would counterbalance any increase in p21 levels arising from SOCS1-dependent p53 activation, ultimately leading to diminished NRF2 activation and increased cell death in SOCS1-expressing cancer cells exposed to oxidative stress.